Today: 21 May 2026
IonQ stock falls despite South Korea quantum-system deal as sector cools
29 December 2025
1 min read

IonQ stock falls despite South Korea quantum-system deal as sector cools

NEW YORK, December 29, 2025, 14:02 ET — Regular session

  • IonQ shares fell 2.5% to $44.85 in afternoon trading.
  • The company said it finalized an agreement to deliver a 100-qubit “Tempo 100” system to South Korea’s KISTI. IonQ Investors
  • Other U.S.-listed quantum names were mixed as investors pared risk into year-end trading.

IonQ shares fell 2.5% to $44.85 in afternoon trading on Monday after the quantum-computing company said it had finalized an agreement to deliver a 100-qubit system to South Korea’s Korea Institute of Science and Technology Information (KISTI).

The agreement adds to a string of government and enterprise projects that investors see as a key test for whether quantum computing can move from research to recurring commercial deployments. The group has been volatile into year-end as traders lock in gains amid low holiday volume and concerns about rich valuations, Investors.com reported.

IonQ said its Tempo 100 system will be integrated into KISTI-6, known as “HANGANG,” the country’s largest high-performance computing (HPC) cluster — essentially a national-scale supercomputer. The company said the setup would be South Korea’s first on-site “hybrid” integration linking quantum hardware with classical computing; a qubit is the basic unit of information in a quantum computer. IonQ Investors

“We deploy our most advanced quantum systems to address the nation’s most significant research and innovation challenges,” IonQ Chairman and CEO Niccolo de Masi said in a statement. IonQ Investors

IonQ did not disclose financial terms or a delivery timeline. The company said access to the platform will be provided through a secure private cloud, allowing remote use by researchers, universities and enterprises in South Korea.

The pullback came alongside uneven moves in other U.S.-listed quantum plays. Rigetti Computing fell about 2% and Quantum Computing Inc slid about 2.8%, while D-Wave Quantum rose about 0.6%.

Quantum stocks have seesawed in recent sessions, with Investors.com pointing to profit-taking after a sector pop on Dec. 22 and a three-session slide that followed.

IonQ traded between $44.71 and $46.74 on Monday, with about 11.1 million shares changing hands by mid-afternoon.

KISTI will lead development of a quantum computing service and research platform, and IonQ said KISTI identified IonQ as the project’s primary quantum technology provider alongside Megazone Cloud.

For investors, the next question is whether headline partnerships translate into recognized revenue and repeat customers, with deliveries and milestones often taking time to show up in reported results. Competition remains intense, including from larger tech companies investing in their own quantum programs, Investors.com noted.

IonQ last reported quarterly results on Nov. 5 and gave a business update for the quarter ended Sept. 30, according to the company’s website.

Nasdaq’s earnings page listed no confirmed date for IonQ’s next report, leaving traders focused on any updates to delivery schedules, contract values and customer wins as year-end liquidity thins.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award
Previous Story

Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award

Synopsys stock today rises as tech slips, Dec. 30 lawsuit deadline nears
Next Story

Synopsys stock today rises as tech slips, Dec. 30 lawsuit deadline nears

Go toTop